SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Jiang Shuling – ‘3’ for 5/20/22 re: Abvc Biopharma, Inc.

On:  Tuesday, 7/12/22, at 5:01pm ET   ·   For:  5/20/22   ·   As:  Director and 10% Owner   ·   Accession #:  1213900-22-38904   ·   File #:  1-40700

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/12/22  Jiang Shuling                     3          Dir.,%Own.  1:4K   Abvc Biopharma, Inc.              EdgarAgents LLC/FA

Initial Statement of Beneficial Ownership of Securities by an Insider   —   Form 3   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 3           Initial Statement of Beneficial Ownership of        HTML      5K 
                Securities by an Insider -- ownership.xml/2.6                    




        

This ‘3’ Document is an XML Data File that may be rendered in various formats:

  Form 3    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
Plain Text rendering:  Initial Statement of Beneficial Ownership of Securities by an Insider
 
                                                                                                                                                                                
Ownership Document
 
Schema Version:  X0206
Document Type:  3
Period of Report:  5/20/22
No Securities Owned:  0
Issuer:
Issuer CIK:  1173313
Issuer Name:  ABVC BIOPHARMA, INC.
Issuer Trading Symbol:  ABVC
Reporting Owner:
Reporting Owner ID:
Owner CIK:  1934554
Owner Name:  Jiang Shuling
Reporting Owner Address:
Owner Street 1:  44370 OLD WARM SPRINGS BLVD.
Owner Street 2:
Owner City:  FREMONT
Owner State:  CA
Owner ZIP Code:  94538
Owner State Description:
Reporting Owner Relationship:
Is Director?  Yes
Is Officer?  No
Is Ten Percent Owner?  Yes
Is Other?  No
Officer Title:
Other Text:
Non-Derivative Table:
Non-Derivative Holding:
Security Title:
Value:  Common Stock
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  7,908,805
Ownership Nature:
Direct or Indirect Ownership:
Value:  I
Nature of Ownership:
Value:  See Footnote
Footnote ID:  F1
Footnotes:
Footnote - F1Ms. Jiang owns 213,120 shares through Keypoint Technology Ltd., over which she has sole voting control, 538,429 through her 80% ownership of Lion Arts, 6,620,981 through Lion Arts' ownership of YuanGene Corporation, 71,685 shares through her ownership of BioFirst, 1,415 shares through her ownership of BioLite, 381,193 shares through her ownership of Liongene, 12,228 shares through her ownership of Rgene, 5,540 shares through her ownership of Genpro Investment, and 64,215 shares directly.
Owner Signature:
Signature Name:  /s/ Shuliang Jiang
Signature Date:  7/12/22


Top
Filing Submission 0001213900-22-038904   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 1, 7:50:44.1am ET